Anti-huLRRC15 antibody drug conjugates and methods for their use
US11045480B2 · kind B2 · utility
0Cited by
45References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 13, 2018 |
| Grant date | Jun 29, 2021 |
| Priority date | — |
| Expiry date | Jul 31, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.